BioNTech says has supplied more than 1 bln COVID-19 vaccine doses so far

Reuters2021-08-09

FRANKFURT, Aug 9 (Reuters) - BioNTech and partner Pfizer have supplied more than one billion doses of their COVID-19 vaccine as per July 21, a bigger number than delivered by competitor AstraZeneca , the German biotech group said on Monday.

AstraZeneca said on July 29 that it and its manufacturing partner, India-based Serum Institute, had supplied a billion doses to 170 countries at the time.

Based on delivery contracts so far, BioNTech said in a statement it expects 15.9 billion euros ($18.7 billion) in revenue accruing to it from the vaccine this year, up from a forecast in May of 12.4 billion euros.

That includes sales, milestone payments from partners and a share of gross profit in its partners' territories, the company added. ($1 = 0.8509 euros)

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

  • TK360
    2021-08-10
    TK360
    Nice 
  • Chanyt
    2021-08-09
    Chanyt
    [Smile] 
  • AuroraJ
    2021-08-09
    AuroraJ
    Well, it's pandemic.. 😢
  • Firefire
    2021-08-09
    Firefire
    Great!
  • Sumei
    2021-08-09
    Sumei
    BNTX has a lot more growth potential in my opinion. It is a biotechnology company that’s actually focused in developing treatments for cancer. And finding treatments for cancer is a huge industry. 
  • 股市搜搜搜
    2021-08-09
    股市搜搜搜
    Good
发表看法
24